Académique Documents
Professionnel Documents
Culture Documents
Anticoagulants and
Antibiotics
Devinda Jayewardene
Case 1
52 year old woman, sudden SOB D3 post lap
cholecystectomy.
1.
2.
3.
4.
5.
Heparins
MoA UFH effects thrombin and Xa, LMWH just effects Xa
ADRs
Type A haemorrhage (major ICH, GIT, minor epistaxis, bruising)
Type B HITS (Ig vs heparin and PF4 complex), hyperkalaemia
Warfarin
MoA inhibits quinine reductase and Vit K epoxide reductase
interfering Vit K metabolism (coenzyme for II, VII, IX, X, protein C and
S)
ADRs
Type A Haemorrhage
Type B teratogen, skin necrosis, zillions of interactions
Monitoring INR
PK liver (P450) and excreted by kidney
Reversal prothrombinex, FFP, Vit K
Cover with heparin in initial stages
Dosage 5 mg OD for 2 days, adjust to INR (2-3 unless heart valves),
NOACs
Xa Inhibitors have xa in name (rivaroxaban,
apixaban)
Direct thrombin inhibitors dabigatran
Dont need monitoring
No antidote
Case 40 F
12 days febrile, cough productive of little sputum,
malaise, lethargy
VS HR 120, BP 140/90, RR 26 Temp 37.8
Creps over all lung fields
Sees GP, given Amoxicillin and sent home
Pdx? Ddx?
How would you judge if she needs admission?
Ix?
Antimicrobials - Targets
Cell Wall B Lactams, Vancomycin
Ribosomal
30S Aminoglycosides, Tetracyclines, 50S Chloramphenicol,
Erythromycin and macrolides, Lincosamides
Buy AT 30 CEL at 50
DNA
Nucleotide synthesis
DNA
Wall Inhibitors
MoA?
Examples?
Spectrum of Activity?
ADRs?
Spectrum
Pencillins G+, Neiserria meningitidis, syphilis
Ampicillin/Amoxicillin G- coverage (HELPSS kill Enterococci - HiB, E.
Coli, Listeria, Proteus, Salmonella, Shigella, Enteroccoci)
Penicillinase Resistance di/flucloxacillin, +clav/tazobactam
Anti-Pseudomonal tic- or piperacillin
Vancomycin G+ (MRSA), Enterococci, C. Diff
Carbopenems Nukes
Interactions
Beta-Lactams clotting drugs (prolongs BT)
Cephalosporins increase aminoglycoside nephrotoxicity
PK
Partial hepatic metabolism, mainly kidney excretion, ceftriaxone 40% biliary
Macrolides
Prevents translocation (macroSLIDES) 50S
A: GIT distress, candida, B: MACRO motility issues, arrhythmia (QTc), Rash,
Eosinophilia
Half-life Erithro 90 min, Clarith 270 min, Azithro 12-24 hours
Elimination in bile after inactivation in liver
Microbes - Morphology
6 Clinically Relevant G+
Cocci SA, Strep
Rods Spore Forming (Bacillus and Clostridium), Non-Spore Forming
(Listeria, Corynebacterium)
Aetiologies of Pneumonia
Typical Strep. Pneumoniae, HiB, SA, Moraxella
Catarrhalis
Atypical viral, mycoplasma pneumonia, legionella,
chlamydia
Antibiotic Management of
Pneumonia
Dependent on type and severity, usually covers both typical and atypical
unless mild
CAP
Outpatient amoxi/doxy/clarith,
Mild inpatient IV Benpen + PO Doxy/Clarith,
Severe IV ceft OR benpen AND gent as well as azithro
Sulfonamides
MoA
ADRs
A: teratogenic, marrow
suppression, (megaloblastic
anaemia, leucopoenia,
granulocytopoenia)
B: hyperkalaemia, rash
B: Hypersensitivity, rash,
nephrotoxic,
photosensitivity, displaces
drugs attached to albumin
(e.g. warfarin), haemolysis
in G6PD
PK
Fluroquinolones (-floxacins)
MoA Inhibit DNA gyrase and topoisomerase IV
impairing DNA organisation after division
ADRs
A: GI distress, superinfection
B: tendonitis and rupture (e.g. Achilles), rashes, headache,
dizziness, some may prolong QT interval
Metronidazole
MoA forms free radicals that damage DNA
Indications anaerobes, protozoa (giardia,
trichomonas), and H. Pylori
ADRs
A: GI distress, C. Diff
B: Disulfiram-like reaction with EtOH, headache, metallic taste